Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Prognostic Models for HCC Based on Tumor Micronecrosis
- Status
- UNKNOWN
- Phase
- N/A
Improving Hepatocellular Carcinoma Screening
- Status
- RECRUITING
- Phase
- NA
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy
- Status
- RECRUITING
- Phase
- N/A
Liver Cancer and Immunotherapy in the Liquid Biopsy Era
- Status
- RECRUITING
- Phase
- NA
Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies
- Status
- RECRUITING
- Phase
- PHASE1
Prognostic Role of HVPG and ICG-R15 in the Short- and Medium-term Results of the Surgery of HCC on Cirrhosis
- Status
- UNKNOWN
- Phase
- N/A
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC
- Status
- TERMINATED
- Phase
- PHASE2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Contrast Enhanced Ultrasound (CEUS) in Atypical Liver Nodules in Patients With Chronic Liver Disease
- Status
- COMPLETED
- Phase
- N/A
The Application of Serum DNA Methylation for Patients With HCC
- Status
- RECRUITING
- Phase
- NA
Ate-Bev Early Response Prediction Model in Advanced HCC
- Status
- RECRUITING
- Phase
- N/A
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
- Status
- UNKNOWN
- Phase
- PHASE2
The Synergistic Effect of Portal Venous Supply Control and Immunotherapy in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A